| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abeona Therapeutics Inc. (ABEO) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ABEO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.31M | $9.01M | -67,971 | |
| CFO | 493.6K | $3.41M | -24,880 | |
| VP | 428.0K | $2.95M | -12,050 | |
| Other | 290.6K | $2.01M | -12,606 | |
| Dir | 48.8K | $336.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2021 | Mann Paul Elliot75 | - | Sale+OE | 45,566 | $2.38 | $108,501.76 | -100% | -34.9% | -90.2% | |
| Feb 18, 2021 | Wider Todd83 | - | Sale+OE | 321,345 | $2.34 | $753,064.79 | -36.7% | -37.4% | -90.4% | |
| Feb 17, 2021 | Mann Paul Elliot75 | - | Sell | 132,664 | $2.34 | $310,168.43 | -100% | -40.7% | -90.8% | |
| Feb 16, 2021 | Sco Capital Partners LLC83 | - | Sell | 120,000 | $2.97 | $356,808.00 | -1.1% | -50.0% | -90.5% | |
| Feb 8, 2021 | Sco Capital Partners LLC83 | - | Sell | 240,000 | $3.01 | $722,832.00 | -2.1% | -60.2% | -92.6% | |
| Jan 19, 2021 | Sco Capital Partners LLC83 | - | Sell | 320,000 | $2.06 | $658,516.23 | -0.9% | - | - | |
| Jan 4, 2021 | Wider Todd83 | Director | Sell | 33,876 | $1.54 | $52,064.02 | -10.9% | - | - | |
| Jan 4, 2021 | Mann Paul Elliot75 | Director | Sell | 30,488 | $1.54 | $46,890.54 | -18.7% | - | - | |
| Dec 18, 2020 | Mann Paul Elliot75 | - | Sell | 17,079 | $1.59 | $27,099.25 | -2.2% | - | - | |
| Dec 2, 2020 | Mann Paul Elliot75 | - | Sell | 30,488 | $1.49 | $45,369.19 | -3.7% | - | - |